SSEA3 and CD105 positivity are associated with the treatment potency of human neural crest-derived nasal turbinate stem cells for Alzheimer’s disease
Our findings suggest that SSEA3/CD105 positivity is a potential marker of NTSC therapeutic efficacy for the treatment of AD. Future studies should focus on enhancing the therapeutic potential of SSEA3<sup>+</sup>/CD105<sup>+</sup> NTSCs by improving their functional efficacy and consistency, and advancing their use in clinical settings.
Authors
- Haewon Shim
- Hyun Kook Lim (ORCID: https://orcid.org/0000-0001-8742-3409)
- Soon A Park
- Seung Ho Yang
- Sin-Soo Jeun
- Sunghwan Kim
- Jung Yeon Lim
- Jung Eun Lee
- Sang In Park
- Sheng-Min Wang
- Minho Lee
- Sung Won Kim
Institutions
- Dongguk University (KR)
- St. Mary's Hospital (US)
- The Catholic University of Korea St. Vincent's Hospital (KR)
- The Catholic University of Korea Incheon St. Mary's Hospital (KR)
- The Catholic University of Korea Yeouido St. Mary's Hospital (KR)
- St Mary's Hospital (GB)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Translational Neurodegeneration
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1186/s40035-026-00539-3
- Primary Topic
- Developmental Biology and Gene Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00